Couling John D — SEC insider filings

SEC reporting owner CIK 1894052. 28 insider filings on record with FilingPulse; latest filed 2026-10-05.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2021-11-17 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Dolby Laboratories, Inc. (DLB)SVP, Entertainment28—37 legs · 439,059 sh · $33,401,03077

Insider filings — Couling John D

FiledFormIssuerReported transactionsSource
2026-10-054Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,667 @ $45.50 · Sale (S): 6,831 @ $58.72 · Sale (S): 836 @ $59.33 · Option exercise (M): 7,667 (derivative) @ $0EDGAR
2026-09-174Dolby Laboratories, Inc. (DLB)Grant/award (A): 48,076 @ $0EDGAR
2026-09-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,667 @ $45.50 · Sale (S): 7,667 @ $61.05 · Option exercise (M): 7,667 (derivative) @ $0EDGAR
2026-08-054Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,667 @ $45.50 · Sale (S): 783 @ $59.03 · Sale (S): 6,884 @ $60.11 · Option exercise (M): 7,667 (derivative) @ $0EDGAR
2026-07-064Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,667 @ $45.50 · Sale (S): 7,667 @ $53.20 · Option exercise (M): 7,667 (derivative) @ $0EDGAR
2026-06-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,666 @ $45.50 · Sale (S): 7,158 @ $55.59 · Sale (S): 508 @ $56.16 · Option exercise (M): 7,666 (derivative) @ $0EDGAR
2026-05-064Dolby Laboratories, Inc. (DLB)Sale (S): 4,688 @ $58.47 · Option exercise (M): 7,666 @ $45.50 · Sale (S): 6,928 @ $57.47 · Sale (S): 738 @ $58.34 · Option exercise (M): 7,666 (derivative) @ $0EDGAR
2026-02-044Dolby Laboratories, Inc. (DLB)Sale (S): 6,667 @ $64.89EDGAR
2025-12-174Dolby Laboratories, Inc. (DLB)Grant/award (A): 25,633 @ $0 · Option exercise (M): 6,825 @ $0 · Tax withholding (F): 8,203 @ $67.54 · Tax withholding (F): 2,612 @ $66.62 · Grant/award (A): 12,816 (derivative) @ $0 · Grant/award (A): 56,440 (derivative) @ $0 · +1 moreEDGAR
2025-12-154Dolby Laboratories, Inc. (DLB)Sale (S): 7,273 @ $68.75EDGAR
2025-11-244Dolby Laboratories, Inc. (DLB)Sale (S): 6,164 @ $66.12EDGAR
2025-05-074Dolby Laboratories, Inc. (DLB)Sale (S): 675 @ $75.04EDGAR
2024-12-184Dolby Laboratories, Inc. (DLB)Grant/award (A): 20,733 @ $0 · Option exercise (M): 5,990 @ $0 · Tax withholding (F): 11,703 @ $79.18 · Grant/award (A): 10,366 (derivative) @ $0 · Grant/award (A): 36,446 (derivative) @ $0 · Option exercise (M): 5,990 (derivative) @ $0EDGAR
2024-11-264Dolby Laboratories, Inc. (DLB)Sale (S): 2,000 @ $81 · Option exercise (M): 40,000 @ $33.15 · Option exercise (M): 8,000 @ $64.60 · Sale (S): 48,000 @ $80 · Option exercise (M): 7,000 @ $64.60 · Sale (S): 7,000 @ $80.50 · +3 moreEDGAR
2024-02-124/ADolby Laboratories, Inc. (DLB)Option exercise (M): 50,000 @ $42.98 · Sale (S): 50,000 @ $80 · Option exercise (M): 12,440 @ $42.98 · Option exercise (M): 21,120 @ $62.32 · Sale (S): 33,560 @ $80.81 · Option exercise (M): 50,000 (derivative) @ $0 · +2 moreEDGAR
2024-02-124Dolby Laboratories, Inc. (DLB)Option exercise (M): 50,000 @ $42.98 · Sale (S): 50,000 @ $80 · Option exercise (M): 12,440 @ $42.98 · Option exercise (M): 21,120 @ $62.32 · Sale (S): 33,560 @ $80.81 · Option exercise (M): 50,000 (derivative) @ $0 · +2 moreEDGAR
2023-12-194Dolby Laboratories, Inc. (DLB)Grant/award (A): 17,303 @ $0 · Option exercise (M): 5,427 @ $0 · Tax withholding (F): 9,093 @ $88.60 · Tax withholding (F): 1,488 @ $87.49 · Grant/award (A): 8,651 (derivative) @ $0 · Grant/award (A): 30,327 (derivative) @ $0 · +1 moreEDGAR
2023-11-174Dolby Laboratories, Inc. (DLB)Sale (S): 79 @ $88.58EDGAR
2023-05-164Dolby Laboratories, Inc. (DLB)Sale (S): 278 @ $83.87EDGAR
2023-02-084Dolby Laboratories, Inc. (DLB)Option exercise (M): 50,000 @ $37.35 · Sale (S): 41,738 @ $84.48 · Sale (S): 8,262 @ $85.24 · Option exercise (M): 15,153 @ $37.35 · Option exercise (M): 21,850 @ $45.50 · Sale (S): 31,202 @ $83.86 · +4 moreEDGAR
2022-12-194Dolby Laboratories, Inc. (DLB)Tax withholding (F): 3,785 @ $73.17 · Grant/award (A): 21,114 @ $0 · Option exercise (M): 4,858 · Tax withholding (F): 3,897 @ $71.07 · Tax withholding (F): 1,240 @ $70.80 · Grant/award (A): 10,557 (derivative) @ $0 · +2 moreEDGAR
2022-11-234Dolby Laboratories, Inc. (DLB)Sale (S): 40 @ $69.02EDGAR
2022-10-054Dolby Laboratories, Inc. (DLB)Option exercise (M): 29,300 @ $30.49 · Sale (S): 29,300 @ $66.30 · Option exercise (M): 20,700 @ $33.15 · Sale (S): 8,680 @ $65.33 · Sale (S): 12,020 @ $65.81 · Option exercise (M): 4,300 @ $33.15 · +4 moreEDGAR
2022-05-174Dolby Laboratories, Inc. (DLB)Sale (S): 185 @ $74.63EDGAR
2022-05-124Dolby Laboratories, Inc. (DLB)Sale (S): 500 @ $72.61 · Sale (S): 1,000 @ $73.00EDGAR
2021-12-204Dolby Laboratories, Inc. (DLB)Tax withholding (F): 1,240 @ $92EDGAR
2021-12-164Dolby Laboratories, Inc. (DLB)Tax withholding (F): 2,119 @ $90.55 · Grant/award (A): 17,027 @ $0 · Tax withholding (F): 1,373 @ $91.80 · Grant/award (A): 8,513 (derivative) @ $0 · Grant/award (A): 35,244 (derivative) @ $0EDGAR
2021-11-174Dolby Laboratories, Inc. (DLB)Sale (S): 87 @ $90.23EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-11-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1894052 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs